In Vitro and In Vivo Performance Testing of a Novel 24F Aspiration/Guide Catheter
Article Information
Michael Bruce Horowitz1*, Benjamin Bob2, Brandon Repko3, Hieu Le2
1First Coast Neurological Surgery and Retriever Medical, Orange Park, FL, USA
2Retriever Medical, Inc, Las Vegas, Nevada, USA
3Department of Radiology, Butler Health System and Retriever Medica, Las Vegas, Nevada, USA
*Corresponding authors: Michael Bruce Horowitz, HCA Orange Park Hospital, 1825 Kingsley Avenue, Suite 170, Orange Park, Florida, USA.
Received: 02 April 2024; Accepted: 08 April 2024; Published: 19 April 2024
Citation: Michael Bruce Horowitz, Benjamin Bobo, Brandon Repko, Hieu Le. In Vitro and In Vivo Performance Testing of a Novel 24F Aspiration/Guide Catheter. Cardiology and Cardiovascular Medicine. 8 (2024): 151-153.
View / Download Pdf Share at FacebookAbstract
This report documents the performance of a novel 24F aspiration/guide catheter (8 mm OD; 7.1 mm ID) manufactured by Retriever Medical Inc. (Las Vegas, Nevada, USA) using in vitro and in vivo modeling. Results demonstrated excellent trackability with ability to navigate tortuous anatomy and serial 90 - 180 degree turns. At a radius of curvature of 6 mm, catheter ovalization (lumen collapse) was not encountered while it was encountered in a similar 24F catheter that at baseline (when positioned straight) had an inner ID 0.2 mm smaller than the novel catheter studied in this report. The capability of the Retriever Medical,Inc 24 F catheter to navigate tortuous anatomy without associated luminal collapse makes it an ideal conduit for thrombus aspiration with and without simultaneous use of a transaxially delivered mechanical thrombectomy device.
Keywords
Catheter; Testing; Retriever; Thrombectomy
Article Details
1. Introduction
Percutaneous endovascular thrombectomy procedures for the treatment of deep venous thrombosis (DVT), pulmonary embolism (PE) and peripheral arterial thromboembolic occlusion necessitates the availability of large bore catheters that, despite their size, can readily navigate through tortuous anatomy without risk of kinking or ovalization. Distortion of such devices’ inner diameters can significantly hamper a surgeon’s ability to generate the vacuum forces needed to aspirate thromboemboli. Distortion can also make delivery of coaxially placed mechanical thrombectomy devices difficult or impossible due to catheter lumen collapse. This report documents the capability of a novel catheter system to traverse tortuous anatomy both in vitro and in vivo.
2. Device Description
Retriever Medical (Las Vegas, Nevada, USA) thrombectomy catheters are designed for aspiration and guide purposes and are available in 24F (8 mm OD; 7.1 mm ID), 20F (6.7mm OD; 5.8 mm ID), and 16F (5.3 mm OD, 4.6 mm ID). Catheters come with both unshaped and pre-shaped tip versions making access to peripheral veins, pulmonary arteries and pulmonary artery branches possible (Figure 1). Each of these catheters will permit advancement of the Retriever Clot Hound mechanical thrombectomy device (Figure 2) through the catheter’s lumen without negating the ability to contiinue to aspirate during simultaneous use of the mechanical device.
Figure 1: (A) 24F angled pulmonary artery guide/aspiration catheter for PE thrombectomy; (B) Preshaped curved 20F pulmonary artery guide/aspiration catheter for engaging and entering more distal PA branch vessels for PE thrombectomy; (C) 16F straight venous guide/aspiration catheter for DVT thrombectomy.
3. Methods
In this study, the Retriever Medical 24F aspiration/guide catheter (8 mm OD; 7.1 mm ID) was tested both in vitro and in vivo using mechanical radius bending and an anesthetized living animal porcine subject. Direct visualization and X-ray fluoroscopy provided visualization of catheter contour. Radius of curvature and angular measurements were made using the catheter’s manufactured diameters to account for fluoroscopic magnification.
4. Results
4.1 Mechanical radius bending
Mechanical radius bending was used to place the 24F catheter into a radius of curvature measuring approximately 6 mm and angulation of 180 degrees. No kinking was identified. A control was performed with another manufacturer’s 24F aspiration catheter with a 0.2 mm smaller ID (8 mm OD; 6.9 mm ID) which demonstrated catheter kinking and ovalization at a radius of curvature of approximately 6 mm and angulation of 180 degrees thus demonstrating the test’s usefulness in detecting device distortion in a tortuous setting (Figure 3). Ovalization reduced the available ID cross sectional area such that it was 10% less than in the non-distorted Retriever catheter.
Figure 3: Left image shows currently available 24F catheter bent with radius of curvature of approximately 6 mm and 180 degrees. Red arrows point to region of catheter ovalization; Right image shows Retriever Medical’s 24 F catheter with radius of curvature of approximately 6 mm and 180 degrees. The ovalization reduces the ID area to 0.48 inch2 compared to 0.53 inch2 in the non-ovalized Retriever catheter (10% reduction in cross sectional area).
4.2 In vivo Porcine Model:
When the 24F device was advanced over a wire from the femoral artery to the distal left pulmonary artery in a 79 kg porcine subject, no kinking was identified under fluoroscopic imaging despite navigation of vascular turns measuring <10 mm radius of curvature at 180 degrees (Figure 3). Aspiration of material from the left pulmonary artery was no different from that experienced when aspirating through a straight catheter. A Retriever Medical mechanical thrombectomy device easily advanced through the 24F catheter’s lumen without noticeable resistance. The device could also be advanced through the 20F and 16F catheters without resistance. Each of the different catheter’s ID dimensions permitted for simultaneous aspiration and mechanical thrombectomy (Figure. 4).
Figure 4: (A) Fluoroscopic visualization of the 24F pulmonary aspiration catheter advanced from the right femoral artery into the porcine distal left pulmonary artery. The smallest radius of curvature and largest degree measurement in this image is 5-6mm and 180 degrees, respectively. No kinking or ovalization is identified; (B) Schematic drawing showing 24F catheter positioned in right pulmonary artery proximal to the pulmonary artery embolic clot (red); (C) Fluoroscopic image. Showing Retriever Medical’s mechanical thrombectomy device (arrow) advanced through the 24F catheter (arrowhead) into the distal pulmonary artery; (D) Retriever Medical’s Clot Hound mechanical thrombectomy device shown in (C) advanced through the 24F aspiration/guide. catheter.
5. Discussion
Previous publications have documented the functionality of a variety of endovascular devices developed by the authors to aid in the performance of mechanical thrombectomy in the peripheral and pulmonary vascular environments (1-4). This manuscript describes a novel 24F guide/aspiration catheter measuring 8 mm OD and 7.1 mm ID that has no difficulty advancing through tortuous in vitro and in vivo test settings that aimed to mimic those curvatures encountered during human endovascular thrombectomy procedures. Catheter kinking was not encountered despite radius of curvature and degree of curvature <10mm at 180 degrees, respectively. These test settings were validated by showing kinking of a similar device made by another manufacturer when the catheter was subjected to near identical radius of curvature and angulation.
6. Conclusion
Retriever Medical’s 24F large bore delivery and aspiration catheter demonstrates absence of kinking and distortion when tested in both in vitro and in vivo settings that mimic those stresses encountered during human endovascular procedures for peripheral and pulmonary thrombectomy. The ID of the 24F, 20F and 16F catheters permitted simultaneous aspiration during coaxial delivery of Retriever Medical’s mechanical thrombectomy device.
Author Responsibilities:
MH: Manuscript preparation; BB: Manuscript preparation; BR: Manuscript preparation; HL: Manuscript preparation
Competing Interests
MH: Founder and Partner Retriever Medical, LLC; BB: Founder, Partner and CEO Retriever Medical, LLC; BR: Chief Science Officer Retriever Medical, LLC; HL: Vice-President Research and Development Retriever Medical, Inc.
Declarations
Ethics approval
This article does not report intervention results on human participants. Animal use was approved by the State University of New York at Buffalo, Canon Stroke and Vascular Research Center IRB # NSG07123N. Human blood was personally provided by the author (MH) and routine laboratory testing was performed. IRB approval was not required for testing of the author’s (MH) blood. All data is publishable under the IRB Board guidelines and consent for use of blood test results from the author’s (MH) blood has been provided by MH.
Funding
Funding for this study was provided by Retriever Medical, Inc..
Availability of data and materials
All data sets have been provided in the Manuscript’s Results section. Any additional information regarding the tested device can be obtained through the corresponding author (MH).
References
- Horowitz M, Bobo B, Repko B, et al. Extra-Corporeal Processing of Bovine, Porcine and Human Blood in Preparation for Autologous Re-Infusion Using a Disposable Filtration System: Initial Proof of Concept Study and Potential Applications for Human Autologous Blood Reinfusion in the Civilian and Combat Casualty Care Settings. Journal of Biology and Today's World 12 (2023): 001-006.
- Horowitz MB, Repko Le H, et al. In Vitro Proof of Concept Evaluation of a Gravity Powered Novel Filtration Device to Effectively Process a Blood Analogue/Particle Mixture to Rapidly Produce a Clear Filtrate. Cardiology and Cardiovascular Medicine 8 (2024).
- Horowitz MB, Repko B, Le H, et al. Porcine Testing of a Novel Second Generation Mechanical Thrombectomy Device to Evaluate Effects on Arterial and Venous Intima and Vessel Integrity. Journal of Biology and Today's World 11 (2022): 001-004.
- Horowitz MB, Sattell J, Repko B, et al. In Vitro Proof of Concept Evaluation of the Radial Force Generated by a Novel Mechanical Thrombectomy Device that Incorporates Controlled, Expandable Wire Spheres. Cardiology and Cardiovascular Medicine 8 (2024).